Jefferson M Jones1, Mathew R P Sapiano1, Alexandra A Savinkina1,2, Kathryn A Haass1, Misha L Baker3, Richard A Henry4, James J Berger4, Sridhar V Basavaraju1. 1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee. 3. Northrup Grumman Corporation, Atlanta, Georgia. 4. U.S. Department of Health and Human Services, Office of HIV/AIDS and infectious Disease Policy, Office of the Assistant Secretary for Health, Washington, DC.
Abstract
INTRODUCTION: The National Blood Collection and Utilization Survey (NBCUS) has demonstrated declines in blood collection and transfusion in the United States since 2008, including declines of 11.6% in red blood cell (RBC) collections and 13.9% in RBC transfusions during 2013-2015. This study described the 2017 NBCUS results. METHODS: The 2017 NBCUS was distributed to all US blood collection centers, all hospitals performing at least 1000 surgeries annually, and a 40% random sample of hospitals performing 100 to 999 surgeries annually. Weighting and imputation were used to generate national estimates for units of blood and components collected, deferred, distributed, transfused, and outdated. RESULTS: Response rates for the 2017 NBCUS were 88% for blood collection centers and 86% for transfusing hospitals. Compared with 2015, the number of RBC units collected during 2017 (12,211,000; 95% confidence interval [CI], 11,680,000-12,742,000) declined by 3.0%, and transfused RBC units (10,654,000, 95% CI, 10,314,000-10,995,000) declined by 6.1%. Distributed platelet (PLT) units (2,560,000; 95% CI, 2,391,000-2,730,000 units) increased by 5.1%, and transfused PLT units (1,937,000, 95% CI, 1,794,000-2,079,000) declined by 2.3%. Distributed plasma units (3,209,000; 95% CI, 2,879,000-3,539,000) declined by 13.6%, and transfused plasma units (2,374,000; 95% CI, 2,262,000-2,487,000) declined by 12.9%. CONCLUSION: The 2017 NBCUS suggests a continued but slowing decline in demand for RBCs. The decline in blood collection and use will likely continue. Despite decreasing demand and increasing manufacturing costs of blood products, the US blood industry has met the regular and emergent needs of the country. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
INTRODUCTION: The National Blood Collection and Utilization Survey (NBCUS) has demonstrated declines in blood collection and transfusion in the United States since 2008, including declines of 11.6% in red blood cell (RBC) collections and 13.9% in RBC transfusions during 2013-2015. This study described the 2017 NBCUS results. METHODS: The 2017 NBCUS was distributed to all US blood collection centers, all hospitals performing at least 1000 surgeries annually, and a 40% random sample of hospitals performing 100 to 999 surgeries annually. Weighting and imputation were used to generate national estimates for units of blood and components collected, deferred, distributed, transfused, and outdated. RESULTS: Response rates for the 2017 NBCUS were 88% for blood collection centers and 86% for transfusing hospitals. Compared with 2015, the number of RBC units collected during 2017 (12,211,000; 95% confidence interval [CI], 11,680,000-12,742,000) declined by 3.0%, and transfused RBC units (10,654,000, 95% CI, 10,314,000-10,995,000) declined by 6.1%. Distributed platelet (PLT) units (2,560,000; 95% CI, 2,391,000-2,730,000 units) increased by 5.1%, and transfused PLT units (1,937,000, 95% CI, 1,794,000-2,079,000) declined by 2.3%. Distributed plasma units (3,209,000; 95% CI, 2,879,000-3,539,000) declined by 13.6%, and transfused plasma units (2,374,000; 95% CI, 2,262,000-2,487,000) declined by 12.9%. CONCLUSION: The 2017 NBCUS suggests a continued but slowing decline in demand for RBCs. The decline in blood collection and use will likely continue. Despite decreasing demand and increasing manufacturing costs of blood products, the US blood industry has met the regular and emergent needs of the country. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Katerina Pavenski; Simon Stanworth; Mark Fung; Erica M Wood; Joanne Pink; Michael F Murphy; Heather Hume; Susan Nahirniak; Kathryn E Webert; Susano Tanael; Denise Landry; Nadine Shehata Journal: Transfus Med Rev Date: 2018-06-01
Authors: Jeffrey L Carson; Gordon Guyatt; Nancy M Heddle; Brenda J Grossman; Claudia S Cohn; Mark K Fung; Terry Gernsheimer; John B Holcomb; Lewis J Kaplan; Louis M Katz; Nikki Peterson; Glenn Ramsey; Sunil V Rao; John D Roback; Aryeh Shander; Aaron A R Tobian Journal: JAMA Date: 2016-11-15 Impact factor: 56.272
Authors: Mathew R P Sapiano; Alexandra A Savinkina; Katherine D Ellingson; Kathryn A Haass; Misha L Baker; Richard A Henry; James J Berger; Matthew J Kuehnert; Sridhar V Basavaraju Journal: Transfusion Date: 2017-06 Impact factor: 3.157
Authors: Jeremy W Cannon; Mansoor A Khan; Ali S Raja; Mitchell J Cohen; John J Como; Bryan A Cotton; Joseph J Dubose; Erin E Fox; Kenji Inaba; Carlos J Rodriguez; John B Holcomb; Juan C Duchesne Journal: J Trauma Acute Care Surg Date: 2017-03 Impact factor: 3.313
Authors: Sanjida J Mowla; Ian T Kracalik; Mathew R P Sapiano; Lynne O'Hearn; Chester Andrzejewski; Sridhar V Basavaraju Journal: Transfus Med Rev Date: 2021-04-02
Authors: Eduard Grebe; Michael P Busch; Edward P Notari; Roberta Bruhn; Claire Quiner; Daniel Hindes; Mars Stone; Sonia Bakkour; Hong Yang; Phillip Williamson; Debra Kessler; Rita Reik; Susan L Stramer; Simone A Glynn; Steven A Anderson; Alan E Williams; Brian Custer Journal: Blood Date: 2020-09-10 Impact factor: 22.113
Authors: Jefferson M Jones; Mathew R P Sapiano; Sanjida Mowla; Dorothy Bota; James J Berger; Sridhar V Basavaraju Journal: Transfusion Date: 2021-06-24 Impact factor: 3.337
Authors: Sanjida J Mowla; Mathew R P Sapiano; Jefferson M Jones; James J Berger; Sridhar V Basavaraju Journal: Transfusion Date: 2021-08-01 Impact factor: 3.337